On December 18, 2024, Esousa Group Holdings LLC and Michael Wachs acquired a significant stake in Nukkleus Inc. The transaction involved 230,000 shares of common stock, 1,436,666 pre-funded warrants, and 2,499,999 warrants, potentially representing 4,166,665 shares or 9.99% of Nukkleus's outstanding common stock.The acquisition is subject to beneficial ownership limitations. Pre-funded warrants have a 4.99% ownership cap, while regular warrants are limited to 9.99%. These restrictions prevent the full exercise of all warrants as of the filing date. The percentage calculation is based on 4,660,431 shares, including 3,222,931 outstanding shares, 230,000 issued to the reporting persons, and 1,437,500 issued to company insiders.Esousa Group Holdings LLC, a New York-based entity, and Michael Wachs, a U.S. citizen, filed this joint Schedule 13G on December 23, 2024. They affirm that the securities were not acquired to change or influence control of Nukkleus Inc.

On December 18, 2024, Esousa Group Holdings LLC and Michael Wachs acquired a significant stake in Nukkleus Inc. The transaction involved 230,000 shares of common stock, 1,436,666 pre-funded warrants, and 2,499,999 warrants, potentially representing 4,166,665 shares or 9.99% of Nukkleus's outstanding common stock.The acquisition is subject to beneficial ownership limitations. Pre-funded warrants have a 4.99% ownership cap, while regular warrants are limited to 9.99%. These restrictions prevent the full exercise of all warrants as of the filing date. The percentage calculation is based on 4,660,431 shares, including 3,222,931 outstanding shares, 230,000 issued to the reporting persons, and 1,437,500 issued to company insiders.Esousa Group Holdings LLC, a New York-based entity, and Michael Wachs, a U.S. citizen, filed this joint Schedule 13G on December 23, 2024. They affirm that the securities were not acquired to change or influence control of Nukkleus Inc.